Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126602681 | 12660268 | 1 | I | 20160531 | 20160705 | 20160817 | 20160817 | PER | US-FRI-1000085968 | FOREST | 52.25 | YR | M | Y | 0.00000 | 20160817 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126602681 | 12660268 | 1 | PS | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | U | 20822 | |||||||||||
| 126602681 | 12660268 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 20 MG EVERY 12 HOURS | 0 | 10 | MG | TABLETS | BID | ||||||
| 126602681 | 12660268 | 3 | C | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | 100 MG AT BEDTIME | 0 | 100 | MG | QD | ||||||||
| 126602681 | 12660268 | 4 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | 20 MG AT BEDTIME | 0 | 20 | MG | QD | ||||||||
| 126602681 | 12660268 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | 900 MG | 0 | 300 | MG | TID | ||||||||
| 126602681 | 12660268 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 25 MG | 0 | 12.5 | MG | BID | ||||||||
| 126602681 | 12660268 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG IN THE MORNING | 0 | 1 | MG | QD | ||||||||
| 126602681 | 12660268 | 8 | C | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | 0.5 MG | 0 | .5 | MG | QD | ||||||||
| 126602681 | 12660268 | 9 | C | METHENAMINE | METHENAMINE | 1 | 2 GRAM | 0 | 1 | G | BID | ||||||||
| 126602681 | 12660268 | 10 | C | BACLOFEN. | BACLOFEN | 1 | 20 MG | 0 | 10 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126602681 | 12660268 | 1 | Product used for unknown indication |
| 126602681 | 12660268 | 2 | Gait disturbance |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126602681 | 12660268 | OT |
| 126602681 | 12660268 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126602681 | 12660268 | Abdominal pain upper | |
| 126602681 | 12660268 | Depressed mood | |
| 126602681 | 12660268 | Dysuria | |
| 126602681 | 12660268 | Feeling guilty | |
| 126602681 | 12660268 | Pyrexia | |
| 126602681 | 12660268 | Suicide attempt | |
| 126602681 | 12660268 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126602681 | 12660268 | 2 | 201512 | 0 |